<DOC>
	<DOCNO>NCT01199185</DOCNO>
	<brief_summary>Obesity represent chronic disease associate significant cardiovascular disease ( CVD ) morbidity mortality . Weight gain young adult adversely impact development CVD risk factor . Further , clear relationship weight loss obese person reduction CVD risk factor . Unfortunately , young adult high risk weight gain . Although scientific literature contain number report regard successful weight loss efficacy study , young adult typically underrepresented . Cigarette smoke lead preventable cause morbidity mortality , quit smoke frequently result significant weight gain . Proactive tobacco quit line use behavioral smoking cessation intervention combine nicotine replacement therapy ( NRT ) show help person quit smoking . However , concern post-cessation weight gain report significant barrier quit many smoker particularly young adult . If efficacious behavioral weight loss program could combine efficacious behavioral smoking cessation program prevent significantly attenuate post-cessation weight gain , large public health benefit may result . Such combined weight loss/ weight gain prevention / smoke cessation program use target intervention strategy young adult , remove barrier participation , utilize interactive technology appeal age group . To date combine program test young adult cigarette smoker . Therefore , objective clinical trial develop test behavioral weight loss / weight gain prevention intervention deliver interactive technology use conjunction efficacious tobacco quit line . A total 330 participant necessary adequately address follow specific aim .</brief_summary>
	<brief_title>Treating Adults Risk Weight Gain With Interactive Technology</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<criteria>The selection criterion clinical trial design include wide range participant study sample representative broad U.S. population Memphis metropolitan area . Those might risk adverse outcome study intervention exclude ( see exclusion criterion ) . All participant give voluntary consent screen visit signing informed consent statement approve Institutional Review Board ( IRB ) . We encourage participation woman minority . The study open person race gender : 1 . *18 35 year old 2 . BMI &gt; 22 kg / m2 3 . Self report smoke &gt; 10 cigarette day 4 . Have access telephone internet 5 . Demonstrate ability access specific web site 6 . Demonstrate ability receive respond email 7 . Willing accept random assignment 8 . *Intending available 24 month intervention 9 . *At risk weight gain ( e.g . plan quit smoke ) Persons exclude TARGIT study follow : 1 . *Current participation commercial weight loss program ( e.g . Weight Watchers , Jenny Craig , etc . ) , current use prescription weight loss medication , plan weight loss surgery within next 24 month ( e.g . gastric bypass , lap band , liposuction ) , current plan enrollment another diet / physical activity / weight loss study 2 . Currently meet recommendation physical activity ( i.e. , 30 minute moderate physical activity per day majority day week 150 minute week ) 3 . *History cerebral , coronary , peripheral vascular disease , serious uncontrolled cardiac arrhythmia , revascularization procedure uncontrolled congestive heart failure past 6 month 4 . Current substance abuse ( include alcohol use excess 21 drink week ) 5 . Uncontrolled hypertension define BP &gt; 140/90 mm Hg 6 . Presence unstable psychiatric condition use antipsychotic drug 7 . History significant kidney disease liver disease 8 . History uncontrolled thyroid disease pheochromocytoma 9 . Current use medication may interfere primary study endpoint ( e.g . weight loss medication Orlistat , etc ) may increase risk side effect study intervention discontinue 10 . Severe uncontrolled asthma , bronchitis , emphysema precludes exercise 11 . Resting heart rate &gt; 100 12 . *Malignancy last 5 year ( except nonmelanoma skin cancer ) 13 . Plans move Memphis metropolitan area next two year 14 . Current participation another clinical trial 15 . *Other medical behavioral factor , judgment Principal Investigator , may interfere study participation ability follow intervention protocol 16 . *History diabetes treat medication may cause hypoglycemia insulin oral hypoglycemic agent 17 . Known allergy sensitivity nicotine patch 18 . *Currently pregnant give birth within last 6 month , currently lactate breast feeding within last 3 month , actively plan pregnancy within next 24 month 19 . *BMI &lt; 18.5 kg / m2 &gt; 40 kg / m2 20 . *Have household member study staff 21 . *Current treatment eat disorder 22 . *Unable provide inform consent 23 . *Regular use systemic steroid define take medication day week 24 . *Use medication treat attention deficit disorder ( ADD ) attention deficit hyperactivity disorder ( ADHD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>